Clinical significance of GADD153 expression in stage I non-small cell lung cancer

By          

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 408-412

Spandidos Publications

Access to resources Recommend Favorite

Stereotactic Body Radiation Therapy for Stage I Non-small-cell Lung Cancer: A Historical Overview of Clinical Studies

By Onishi Hiroshi   Araki Tsutomu  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 345-350

Oxford University Press

Access to resources Recommend Favorite

Stage I High-Grade Non-Hodgkin's Lymphoma

By Lote Knut   Holte Harald   Nome Ole   Langholm Ruth   Kvaløy Stein  

Acta Oncologica, Vol. 39, Iss. 7, 2000-11 ,pp. : 865-872

Informa Healthcare

Access to resources Recommend Favorite

Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy

By Bebb Gwyn   Smith Colum   Rorke Stewart   Boland William   Nicacio Leonardo   Sukhoo Ryan   Brade Anthony  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 837-845

Springer Publishing Company

Access to resources Recommend Favorite

Video-assisted thoracoscopic surgery and thoracotomy during lobectomy for clinical stage I non-small-cell lung cancer have equivalent oncological outcomes: A single-center experience of 212 consecutive resections

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1364-1372

Spandidos Publications

Access to resources Recommend Favorite